Gitelman-Like Syndrome Secondary to Occupational Solvent Inhalation

Introduction: Gitelman’s syndrome is a renal tubulopathy characterized by hypokalemic metabolic alkalosis with hypomagnesemia and hypocalciuria, due to distal tubular salt wasting. Symptoms include muscle cramps, paresthesias, nocturia, salt craving, weakness, and fatigue. It is caused by biallelic mutations in the SLC12A3 gene, which encodes the thiazide-sensitive NCC transporter. Non-genetic mimics include diuretic use, chronic laxative abuse, prolonged vomiting, certain medications, autoimmune diseases, and pregnancy but not solvent exposure. Case Description: A 62-year-old male patient with hypertension and a history of chronic solvent exposure due to his professional roles as a tinsmith and a painter was admitted to the hospital with complaints including upper limb muscle contractions, paresthesias, and bradycardia (57 beats per minute). Laboratory investigations revealed the presence of chlorine-insensitive metabolic alkalosis, renal-origin hypokalemia, hypomagnesemia, hypocalcemia, neutrophilic leukocytosis, and thrombocytosis. Despite exhaustive investigative efforts, no identifiable infectious source was identified. Consequently, CT scans revealed gastric wall thickening. The findings were attributed to solvent inhalation. Following a period of treatment, the patient was discharged on a medication regimen consisting of telmisartan, spironolactone, potassium, magnesium sulfate, and aspirin. The patient demonstrated notable improvement during their follow up. Discussion: Inhaled solvents can cause various kidney issues, but Gitelman-like syndrome has not been previously reported. This patient had high blood pressure, which is unusual for Gitelman’s syndrome, typically linked to low blood pressure. Elevated white blood cells and platelets were considered reactive. Treatment focused on correcting fluid and electrolyte imbalances, with potassium normalized over 10 days and supplements given. Though genetic testing and renin levels couldn't be measured, the findings indicated a Gitelman-like syndrome caused by solvent inhalation.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.20253hwnwqjk
Primary Topic
Risk and Safety Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gitelman-Like Syndrome Secondary to Occupational Solvent Inhalation

Joana Balderas Juarez, Nancy Julieta González Flores, José Luis Hernández Castillo, Mauricio Adrián Salinas-Ramírez et al.
Journal of the American Society of Nephrology
Risk and Safety Analysis
article

Gitelman-Like Syndrome Secondary to Occupational Solvent Inhalation

Joana Balderas Juarez, Nancy Julieta González Flores, José Luis Hernández Castillo, Mauricio Adrián Salinas-Ramírez, Juan Daniel Diaz Garcia, Sideré Monserrath Zorrilla Alfaro, Jose Luis Mora Lojan
article en

Abstract

Introduction: Gitelman’s syndrome is a renal tubulopathy characterized by hypokalemic metabolic alkalosis with hypomagnesemia and hypocalciuria, due to distal tubular salt wasting. Symptoms include muscle cramps, paresthesias, nocturia, salt craving, weakness, and fatigue. It is caused by biallelic mutations in the SLC12A3 gene, which encodes the thiazide-sensitive NCC transporter. Non-genetic mimics include diuretic use, chronic laxative abuse, prolonged vomiting, certain medications, autoimmune diseases, and pregnancy but not solvent exposure. Case Description: A 62-year-old male patient with hypertension and a history of chronic solvent exposure due to his professional roles as a tinsmith and a painter was admitted to the hospital with complaints including upper limb muscle contractions, paresthesias, and bradycardia (57 beats per minute). Laboratory investigations revealed the presence of chlorine-insensitive metabolic alkalosis, renal-origin hypokalemia, hypomagnesemia, hypocalcemia, neutrophilic leukocytosis, and thrombocytosis. Despite exhaustive investigative efforts, no identifiable infectious source was identified. Consequently, CT scans revealed gastric wall thickening. The findings were attributed to solvent inhalation. Following a period of treatment, the patient was discharged on a medication regimen consisting of telmisartan, spironolactone, potassium, magnesium sulfate, and aspirin. The patient demonstrated notable improvement during their follow up. Discussion: Inhaled solvents can cause various kidney issues, but Gitelman-like syndrome has not been previously reported. This patient had high blood pressure, which is unusual for Gitelman’s syndrome, typically linked to low blood pressure. Elevated white blood cells and platelets were considered reactive. Treatment focused on correcting fluid and electrolyte imbalances, with potassium normalized over 10 days and supplements given. Though genetic testing and renin levels couldn't be measured, the findings indicated a Gitelman-like syndrome caused by solvent inhalation.

Journal of the American Society of NephrologyVol. 36(10S)
Hospital General Dr. Manuel Gea Gonzalez (MX)
Openalex Percentile: Top 70%
Risk and Safety Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.